536 related articles for article (PubMed ID: 8908675)
1. Prostatic and extraprostatic alpha-adrenoceptors--contributions to the lower urinary tract symptoms in benign prostatic hyperplasia.
Andersson KE
Scand J Urol Nephrol Suppl; 1996; 179():105-11. PubMed ID: 8908675
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system.
Andersson KE; Gratzke C
Nat Clin Pract Urol; 2007 Jul; 4(7):368-78. PubMed ID: 17615548
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
[TBL] [Abstract][Full Text] [Related]
4. Alpha-adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists.
Andersson KE
World J Urol; 2002 Apr; 19(6):390-6. PubMed ID: 12022707
[TBL] [Abstract][Full Text] [Related]
5. Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS--implications for clinical practice.
Yassin A; Saad F; Hoesl CE; Traish AM; Hammadeh M; Shabsigh R
Andrologia; 2006 Feb; 38(1):1-12. PubMed ID: 16420236
[TBL] [Abstract][Full Text] [Related]
6. Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance?
Barendrecht MM; Abrams P; Schumacher H; de la Rosette JJ; Michel MC
Neurourol Urodyn; 2008; 27(3):226-30. PubMed ID: 17638312
[TBL] [Abstract][Full Text] [Related]
7. α(1)-Adrenoceptors in the urinary tract.
Yamada S; Ito Y
Handb Exp Pharmacol; 2011; (202):283-306. PubMed ID: 21290232
[TBL] [Abstract][Full Text] [Related]
8. The role of combination medical therapy in benign prostatic hyperplasia.
Greco KA; McVary KT
Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
[TBL] [Abstract][Full Text] [Related]
9. Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?
Carson CC
BJU Int; 2006 Apr; 97 Suppl 2():39-43; discussion 44-5. PubMed ID: 16507053
[TBL] [Abstract][Full Text] [Related]
10. [Uroselectivity of alpha-1 antagonism in the treatment of benign prostatic hypertrophy: on the pharmacologic concept of the clinical approach].
Jolliet P; Bourin M
Therapie; 1998; 53(1):61-6. PubMed ID: 9773101
[TBL] [Abstract][Full Text] [Related]
11. [Benign hypertrophy of the prostate: which treatment, for whom?].
Schulman C
Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
[TBL] [Abstract][Full Text] [Related]
12. Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.
Gallegos PJ; Frazee LA
Pharmacotherapy; 2008 Mar; 28(3):356-65. PubMed ID: 18294115
[TBL] [Abstract][Full Text] [Related]
13. Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms.
Lowe FC
Clin Ther; 2004 Nov; 26(11):1701-13. PubMed ID: 15639685
[TBL] [Abstract][Full Text] [Related]
14. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.
Lowe FC
BJU Int; 2005 Jun; 95 Suppl 4():12-8. PubMed ID: 15871731
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
[TBL] [Abstract][Full Text] [Related]
16. Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia.
Rosen RC
Curr Opin Urol; 2006 Jan; 16(1):11-9. PubMed ID: 16385195
[TBL] [Abstract][Full Text] [Related]
17. Correlation between lower urinary tract symptoms and urethral function in benign prostatic hyperplasia.
Nakai H; Yamanishi T; Yasuda K; Kitahara S; Suzuki T
Neurourol Urodyn; 2004; 23(7):618-22. PubMed ID: 15382181
[TBL] [Abstract][Full Text] [Related]
18. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study.
Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Morrill B; Montorsi F;
J Urol; 2008 Feb; 179(2):616-21; discussion 621. PubMed ID: 18082216
[TBL] [Abstract][Full Text] [Related]
19. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
Miner M; Rosenberg MT; Perelman MA
Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
[TBL] [Abstract][Full Text] [Related]
20. Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia.
Roehrborn CG; Schwinn DA
J Urol; 2004 Mar; 171(3):1029-35. PubMed ID: 14767264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
